Results 161 to 170 of about 192,514 (206)

On-Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles. [PDF]

Small
Zilberzwige-Tal S, Levin A, Ezra A, Elia U, Finkelstein-Zuta G, Kreiser T, Gershon L, Goldsmith M, Kon E, Navon Y, Cohen O, Knowles TP, Peer D, Gazit E.   +13 more
europepmc   +1 more source

Immuno-functionomics reveals geographical variation and a role for TLR8 in mRNA vaccine responses. [PDF]

iScience
Huisman W, Azimi S, Nguyen YN, de Kroon AC, de Ruiter K, Tahapary DL, Manurung MD, Pothast CR, Kruize YCM, Heemskerk MHM, Supali T, Visser LG, Roukens AHE, Yazdanbakhsh M, Jochems SP.   +14 more
europepmc   +1 more source

High levels of nonblocking anti-interferon and anticytokine autoantibodies in individuals with mRNA vaccine-induced systemic allergic reactions. [PDF]

J Allergy Clin Immunol Glob
Kalaycioglu M, Feng A, Dhingra S, Khalid MB, Nadeau KC, Utz PJ, Frischmeyer-Guerrerio PA.   +6 more
europepmc   +1 more source

mRNA Vaccine Technology Beyond COVID-19. [PDF]

Vaccines (Basel)
Oloruntimehin S, Akinyi F, Paul M, Ariyo O.   +3 more
europepmc   +1 more source

A Bivalent mRNA Vaccine Efficiently Prevents Gammaherpesvirus Latent Infection. [PDF]

Vaccines (Basel)
Yin Y, Zang J, Shi H, Wang Z, Kuang L, Wang S, Wang H, Li N, Liang X, Huang Z.   +9 more
europepmc   +1 more source

Author Correction: Development of an mRNA vaccine encoding IHNV glycoprotein protects rainbow trout (Oncorhynchus mykiss) from infection. [PDF]

NPJ Vaccines
Wang J, Wu K, Liu Y, Wang S, Zhao L, Zhang D, Liu R, Ren Y, Shao S, Liu Q.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

mRNA vaccines

Nature Biotechnology, 2021
The concept of developing mRNA as vaccine platform evolved over the last decades. mRNA uses host cells for antigen production, can induce B and T cell responses and does not rely on unwanted antigens that may interfere with booster doses like vector vaccines.
openaire   +3 more sources

Innate sensing of mRNA vaccines

Current Opinion in Immunology, 2022
With the recent success of mRNA vaccines and the approval of several RNA oligonucleotide therapeutics, RNA holds great promise for future drug development. The rise of RNA therapeutics has been enabled by the tremendous progress in our understanding of the sophisticated cellular mechanisms that disarm potentially dangerous exogenous RNA and safeguard ...
Christine, Wuebben, Eva, Bartok, Gunther, Hartmann   +2 more
openaire   +2 more sources

mRNA Cancer Vaccines

2016
mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. The most straightforward use of mRNA vaccines in oncologic settings is the immunization of patients with mRNA vaccines encoding tumor-associated antigens ...
Katja, Fiedler, Sandra, Lazzaro, Johannes, Lutz, Susanne, Rauch, Regina, Heidenreich   +4 more
openaire   +2 more sources